Pharming Group N.V.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $2.9M | $-11.8M | $-10.5M | $13.7M | $16.0M | $37.7M | $40.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $2.1M | $2.3M | $2.4M | $2.6M | $3.2M | $2.9M | — |
| Amortization | $6.5M | $6.3M | $5.9M | $4.3M | $4.2M | $4.0M | — |
| Stock-Based Compensation | $13.8M | $11.3M | $9.3M | $6.4M | $9.1M | $8.4M | $5.0M |
| Net Cash from Operating Activities | $54.7M | $-1.8M | $-17.3M | $22.5M | $37.8M | $83.6M | $74.1M |
| Investing Activities | |||||||
| Capital Expenditures | $749.0K | $790.0K | $1.4M | $1.4M | $10.7M | $4.7M | $2.6M |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $26.3M | $31.6M | $-129.4M | $5.3M | $-21.3M | $-15.6M | $-28.3M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.5M | $-34.4M | $-1.0M | $-5.0M | $-27.9M | $60.7M | $-63.5M |
| Net Change in Cash | — | — | — | — | — | — | — |
| Free Cash Flow | $54.0M | $-2.6M | $-18.7M | $21.1M | $27.1M | $79.0M | $71.5M |